[Comparative evaluation of the long-term results of treatment of cervical cancer using radiocolloids].
The author provided a comparative analysis of the results of therapy of 127 cervical cancer patients. 198Au-(75 patients) and 90Y-colloids (52 patients) were administered intraparametrially for adjuvant radiotherapy. The summary absorbed dose in combined modality radiation therapy was 90-100 Gy at the point A and 40-50 Gy at the point B. The author presented 5- and 10-year survival rates which were higher with 90Y-colloid as compared to those with 198Au-colloid. Early radiation reactions and late radiation injuries developed somewhat more frequently with 90Y. However statistical differences were insignificant. Thus, combined modality radiation therapy of cervical cancer using 90Y-colloid for adjuvant radiotherapy considerably enhances therapeutic efficacy without increasing the number of radiation complications.
D000328:Adult; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006048:Gold Colloid, Radioactive / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
D006048:Gold Colloid, Radioactive; D015021:Yttrium Radioisotopes
Sravnitel'naia otsenka otdalennykh rezul'tatov lecheniia raka sheĭki matki s primeneniem radiokolloidov.